Hospital Mater Dei (BSP:MATD3) Revenue: R$2,251 Mil (TTM As of Mar. 2026)


BSP:MATD3 Hospital Mater Dei SA BSP:MATD3
75 GF Score
Price R$4.84
GF Value R$5.86
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Hospital Mater Dei Revenue?

Hospital Mater Dei BSP:MATD3 +1.47% 75 Revenue is R$2,251 Mil as of Mar. 2026. GuruFocus rates BSP:MATD3 with a GF Score™ of 75/100 and a GF Value™ of R$5.86 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Hospital Mater Dei's revenue for the three months ended in Mar. 2026 was R$575 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was R$2,251 Mil. Hospital Mater Dei's Revenue per Share for the three months ended in Mar. 2026 was R$1.73. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was R$6.69.

During the past 12 months, the average Revenue per Share Growth Rate of Hospital Mater Dei was 15.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 11.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 25.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 9 years, Hospital Mater Dei's highest 3-Year average Revenue per Share Growth Rate was 38.80% per year. The lowest was 11.90% per year. And the median was 24.20% per year.


Hospital Mater Dei  (BSP:MATD3) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Hospital Mater Dei Revenue Related Terms


Hospital Mater Dei Revenue Historical Data

* Premium members only.

The historical data trend for Hospital Mater Dei's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hospital Mater Dei Revenue Chart

Hospital Mater Dei Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Revenue
Get a 7-Day Free Trial Premium Member Only 1,024.31 1,763.13 2,187.67 2,226.00 2,175.29

Hospital Mater Dei Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 499.32 545.81 567.86 562.30 574.96

BSP:MATD3 vs HCA, THC, DVA: Revenue Comparison

For the Medical Care Facilities subindustry, Hospital Mater Dei's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hospital Mater Dei Revenue vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's Revenue distribution charts can be found below:

* The bar in red indicates where Hospital Mater Dei's Revenue falls into.


BSP:MATD3
75GF Score
Hospital Mater Dei SA BSP:MATD3
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hospital Mater Dei Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$2,251 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of R$2,251 Mil mean?
Hospital Mater Dei (BSP:MATD3) has a Revenue of R$2,251 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Hospital Mater Dei and its competitors.
Is Hospital Mater Dei's Revenue too high?
Hospital Mater Dei's current Revenue is R$2,251 Mil. Overall, Hospital Mater Dei has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's Revenue compare to HCA and THC?
Hospital Mater Dei's Revenue of R$2,251 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Hospital Mater Dei and its competitors. Hospital Mater Dei's current Revenue is R$2,251 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.86, compared to a current price of R$4.84 — trading 17.4% below its estimated fair value. The current Revenue is R$2,251 Mil. Hospital Mater Dei's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current Revenue is R$2,251 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?

Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued. The current stock price of R$4.84 is trading 17.4% below its estimated GF Value™ of R$5.86. GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.

Key valuation signals for BSP:MATD3:

  • Revenue: R$2,251 Mil
  • GF Value™: R$5.86 vs. price of R$4.84 (17.4% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hospital Mater Dei Business Description

Address Rua Mato Grosso, No. 1, 100, Bairro Santo Agostinho, Belo Horizonte, MG, BRA, 30.190-081
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
75GF Score

Get the complete analysis for BSP:MATD3

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$4.84
Price
R$5.86
GF Value